SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans
16 references·1 citing·21 second hop
Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans (2020)Brain serotonin 2A receptor binding predi…Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (2019)Psychedelic effects of psiloc…Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Psilocybin with psychological…Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Rapid and sustained symptom r…Psychedelics (2016)PsychedelicsPsilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Psilocybin with psychological…Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin produces substanti…Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin (2015)Validation of the revised Mys…Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (2015)Psilocybin-assisted treatment…Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction (2014)Pilot study of the 5-HT 2A R …Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)Psilocybin occasioned mystica…Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness (2011)Mystical experiences occasion…Human hallucinogen research: guidelines for safety (2008)Human hallucinogen research: …Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Hallucinogens Recruit Specifi…Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder (2006)Safety, Tolerability, and Eff…Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Psilocybin can occasion mysti…Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Psilocybin induces schizophre…Sustained effects of single doses of classical psychedelics in humans (2022)Sustained effects of single d…Hallucinogens (2004)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Psychedelics and the essential importance of context (2018)The varieties of religious experience: A study in human nature. (1902)Universals in the Content and Structure of Values: Theoretical Advances and Empirical Tests in 20 Countries (1992)Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. (2002)Neural correlates of the LSD experience revealed by multimodal neuroimaging (2016)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)DSM‐IV‐TR: Diagnostic and Statistical Manual of Mental Disorders (2013)"Mysticism and Philosophy" (1960)Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Mysticism and Philosophy (2024)Manual for the State-Trait Anxiety Inventory (1970)The Hospital Anxiety and Depression Scale (1983)Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. (1985)Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)Psychedelics Promote Structural and Functional Neural Plasticity (2018)Trial of Psilocybin versus Escitalopram for Depression (2021)The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (2017)Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression (2018)Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (2020)
this work references cited by second hop

References

  • 2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2,196 cited
  • 2016Psychedelics1,757 cited
  • 2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial1,696 cited
  • 2006Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance1,682 cited
  • 2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study1,533 cited
  • 2008Human hallucinogen research: guidelines for safety1,201 cited
  • 2015Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study1,150 cited
  • 1998Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action1,015 cited
  • 2017Psilocybin with psychological support for treatment-resistant depression: six-month follow-up969 cited
  • 2011Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects932 cited
  • 2007Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior922 cited
  • 2014Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction913 cited
  • 2011Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

893 cited
  • 2006Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder789 cited
  • 2015Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin635 cited
  • 2019Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels513 cited
  • Cited by

    • 2022Sustained effects of single doses of classical psychedelics in humans60 cited